Selected research
Industry Growth & Trends
Global Pets Parasiticide Medicines Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Pets Parasiticide Medicines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Pets Parasiticide Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Pets Parasiticide Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pets Parasiticide Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Pets Parasiticide Medicines market include Bimeda Animal Health, Boehringer Ingelheim, Ceva Sante Animale, Elanco, Vetoquinol, Virbac, Zoetis, Bayer and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Pets Parasiticide Medicines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Pets Parasiticide Medicines market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pets Parasiticide Medicines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pets Parasiticide Medicines.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Pets Parasiticide Medicines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Pets Parasiticide Medicines Market by Company
Bimeda Animal Health
Boehringer Ingelheim
Ceva Sante Animale
Elanco
Vetoquinol
Virbac
Zoetis
Bayer
Merck
Pets Parasiticide Medicines Segment by Type
In Vitro Parasiticide Medicines
In Vivo Parasiticide Medicines
Pets Parasiticide Medicines Segment by Application
Cats
Equine
Dogs
Others
Pets Parasiticide Medicines Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pets Parasiticide Medicines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pets Parasiticide Medicines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pets Parasiticide Medicines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Pets Parasiticide Medicines companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- In Vitro Parasiticide Medicines
- In Vivo Parasiticide Medicines
Applications
- Cats
- Equine
- Dogs
- Others
Companies covered
- Bimeda Animal Health
- Boehringer Ingelheim
- Ceva Sante Animale
- Elanco
- Vetoquinol
- Virbac
- Zoetis
- Bayer
- Merck
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Pets Parasiticide Medicines Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Pets Parasiticide Medicines Market Size by Region (2021-2032)
- 1.4.1 Global Pets Parasiticide Medicines Market Size by Region (2021-2026)
- 1.4.2 Global Pets Parasiticide Medicines Market Size by Region (2027-2032)
- 1.5 Key Regions Pets Parasiticide Medicines Market Size (2021-2032)
- 1.5.1 North America Pets Parasiticide Medicines Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Pets Parasiticide Medicines Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Pets Parasiticide Medicines Market Size Growth Rate (2021-2032)
- 1.5.4 South America Pets Parasiticide Medicines Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Pets Parasiticide Medicines Market Size Growth Rate (2021-2032)
2 Pets Parasiticide Medicines Market by Type
- 2.1 Type Introduction
- 2.1.1 In Vitro Parasiticide Medicines
- 2.1.2 In Vivo Parasiticide Medicines
- 2.2 Global Pets Parasiticide Medicines Market Size by Type
- 2.2.1 Global Pets Parasiticide Medicines Market Size Overview by Type (2021-2032)
- 2.2.2 Global Pets Parasiticide Medicines Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Pets Parasiticide Medicines Market Size Forecasted by Type (2027-2032)
- 2.3 Global Pets Parasiticide Medicines Market Size by Regions
- 2.3.1 North America Pets Parasiticide Medicines Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Pets Parasiticide Medicines Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Pets Parasiticide Medicines Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Pets Parasiticide Medicines Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Pets Parasiticide Medicines Market Size Breakdown by Type (2021-2026)
3 Pets Parasiticide Medicines Market by Application
- 3.1 Type Introduction
- 3.1.1 Cats
- 3.1.2 Equine
- 3.1.3 Dogs
- 3.1.4 Others
- 3.2 Global Pets Parasiticide Medicines Market Size by Application
- 3.2.1 Global Pets Parasiticide Medicines Market Size Overview by Application (2021-2032)
- 3.2.2 Global Pets Parasiticide Medicines Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Pets Parasiticide Medicines Market Size Forecasted by Application (2027-2032)
- 3.3 Global Pets Parasiticide Medicines Market Size by Regions
- 3.3.1 North America Pets Parasiticide Medicines Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Pets Parasiticide Medicines Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Pets Parasiticide Medicines Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Pets Parasiticide Medicines Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Pets Parasiticide Medicines Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Pets Parasiticide Medicines Industry Trends
- 4.2 Pets Parasiticide Medicines Industry Drivers
- 4.3 Pets Parasiticide Medicines Industry Opportunities and Challenges
- 4.4 Pets Parasiticide Medicines Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Pets Parasiticide Medicines Revenue (2021-2026)
- 5.2 Global Pets Parasiticide Medicines Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Pets Parasiticide Medicines Key Company Headquarters & Area Served
- 5.4 Global Pets Parasiticide Medicines Company, Product Type & Application
- 5.5 Global Pets Parasiticide Medicines Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Pets Parasiticide Medicines Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Pets Parasiticide Medicines Players Market Share by Revenue in 2025
- 5.6.3 2025 Pets Parasiticide Medicines Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Bimeda Animal Health
- 6.1.1 Bimeda Animal Health Company Information
- 6.1.2 Bimeda Animal Health Business Overview
- 6.1.3 Bimeda Animal Health Pets Parasiticide Medicines Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Bimeda Animal Health Pets Parasiticide Medicines Product Portfolio
- 6.1.5 Bimeda Animal Health Recent Developments
- 6.2 Boehringer Ingelheim
- 6.2.1 Boehringer Ingelheim Company Information
- 6.2.2 Boehringer Ingelheim Business Overview
- 6.2.3 Boehringer Ingelheim Pets Parasiticide Medicines Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Boehringer Ingelheim Pets Parasiticide Medicines Product Portfolio
- 6.2.5 Boehringer Ingelheim Recent Developments
- 6.3 Ceva Sante Animale
- 6.3.1 Ceva Sante Animale Company Information
- 6.3.2 Ceva Sante Animale Business Overview
- 6.3.3 Ceva Sante Animale Pets Parasiticide Medicines Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Ceva Sante Animale Pets Parasiticide Medicines Product Portfolio
- 6.3.5 Ceva Sante Animale Recent Developments
- 6.4 Elanco
- 6.4.1 Elanco Company Information
- 6.4.2 Elanco Business Overview
- 6.4.3 Elanco Pets Parasiticide Medicines Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Elanco Pets Parasiticide Medicines Product Portfolio
- 6.4.5 Elanco Recent Developments
- 6.5 Vetoquinol
- 6.5.1 Vetoquinol Company Information
- 6.5.2 Vetoquinol Business Overview
- 6.5.3 Vetoquinol Pets Parasiticide Medicines Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Vetoquinol Pets Parasiticide Medicines Product Portfolio
- 6.5.5 Vetoquinol Recent Developments
- 6.6 Virbac
- 6.6.1 Virbac Company Information
- 6.6.2 Virbac Business Overview
- 6.6.3 Virbac Pets Parasiticide Medicines Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Virbac Pets Parasiticide Medicines Product Portfolio
- 6.6.5 Virbac Recent Developments
- 6.7 Zoetis
- 6.7.1 Zoetis Company Information
- 6.7.2 Zoetis Business Overview
- 6.7.3 Zoetis Pets Parasiticide Medicines Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Zoetis Pets Parasiticide Medicines Product Portfolio
- 6.7.5 Zoetis Recent Developments
- 6.8 Bayer
- 6.8.1 Bayer Company Information
- 6.8.2 Bayer Business Overview
- 6.8.3 Bayer Pets Parasiticide Medicines Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Bayer Pets Parasiticide Medicines Product Portfolio
- 6.8.5 Bayer Recent Developments
- 6.9 Merck
- 6.9.1 Merck Company Information
- 6.9.2 Merck Business Overview
- 6.9.3 Merck Pets Parasiticide Medicines Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Merck Pets Parasiticide Medicines Product Portfolio
- 6.9.5 Merck Recent Developments
7 North America
- 7.1 North America Pets Parasiticide Medicines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Pets Parasiticide Medicines Market Size by Country (2021-2026)
- 7.3 North America Pets Parasiticide Medicines Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Pets Parasiticide Medicines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Pets Parasiticide Medicines Market Size by Country (2021-2026)
- 8.3 Europe Pets Parasiticide Medicines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Pets Parasiticide Medicines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Pets Parasiticide Medicines Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Pets Parasiticide Medicines Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Pets Parasiticide Medicines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Pets Parasiticide Medicines Market Size by Country (2021-2026)
- 10.3 South America Pets Parasiticide Medicines Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Pets Parasiticide Medicines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Pets Parasiticide Medicines Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Pets Parasiticide Medicines Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst